Novo Holdings is headquartered in Copenhagen and stands as one of the world's largest life sciences investors, managing €142B (roughly $155B) in total AUM as of year-end 2024. The evergreen fund structure — backed by the Novo Nordisk Foundation ecosystem — enables genuinely long-term investment horizons.
In 2024, DKK 4.9B was deployed in venture, including DKK 3.2B across 20 new investments. The ...
New York, United States
New York, United States
Leverkusen, Germany
New York, United States
Singapore, Singapore
Boston, United States